Our program includes a multidisciplinary team, access to innovative treatments, and a commitment to research.
Tag: blood cancer
When Jillian's leukemia relapsed, CAR T-cell therapy was her best option. Here's how the use case for CAR T in treating children's cancer is expanding.
UVA Cancer Center researchers lead acute myeloid leukemia (AML) discovery that could pave the way for improved treatments and patient outcomes.
With acute myeloid leukemia classification overseen by 3 separate guidelines, Firas El Chaer, MD, is working to bring order to the chaos.
Thomas Loughran, MD, reveals the most intriguing clinical applications for his LGL and acute myeloid leukemias research.
UVA researchers are evaluating a novel CAR T-cell in order to expand this therapy to treat patients with untreatable lymphomas.